Clinical Research Directory

Inclusion Criteria: * Pediatric participants between approximately 4 and 12 years of age at the time of enrollment. * Diagnosed with or presenting with neurodevelopmental, neurologic, or genetic conditions, including but not limited to: * cerebral palsy * autism spectrum disorder * developmental delay * hypoxic ischemic encephalopathy (HIE) * traumatic brain injury * sensory processing disorder * chromosomal or genetic abnormalities * Demonstrate functional impairments in one or more neurodevelopmental domains, including: * motor coordination or motor planning * sensory processing * attention or executive functioning * oculomotor or visual processing * communication * emotional or behavioral regulation * activities of daily living * Enrolled in and able to participate in a two-week intensive therapy program consisting of approximately 2.5 hours per day/ 5 days per week * Able to complete baseline and post-program clinical assessment using clinician-observed or caregiver-reported measures. * Parent or legal guardian able to provide informed consent and participate in reporting functional outcomes when applicable. Exclusion Criteria: * Medical instability or acute medical condition that would prevent safe participation in an intensive therapy program. * Severe uncontrolled seizure activity or other neurologic condition that would interfere with participation in structured therapeutic activities, as determined by the treating clinician. * Behavioral or psychological conditions that would prevent safe engagement in the therapy environment despite appropriate support. * Inability to attend or complete the full two-week intensive program. * Lack of sufficient baseline or post-intervention data to assess change in functional performance. * Concurrent participation in another structured intervention or clinical study that would confound interpretation of functional outcomes, at the discretion of the investigator.